Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study
Executive Summary: Background As of December 2020, the COVID-19 pandemic has infected over 80 million people and caused over 1.7 million deaths worldwide. Over 250 thousand cases of infection and over 1800 deaths have occurred in Nepal. An approved antiviral therapy for the treatment of COVID-19 i...
Saved in:
Main Authors: | Gyanwali, Pradeep, Bhattarai, Saroj, Dhimal, Meghnath |
---|---|
Format: | Technical Report |
Language: | en_US |
Published: |
Nepal Health Research Council
2021
|
Subjects: | |
Online Access: | http://103.69.126.140:8080/handle/123456789/743 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of health status of home isolated COVID-19 patients in Nepal
by: Gyanwali, Pradeep, et al.
Published: (2021) -
Assessment of status of post-recovery patients with COVID-19 infections in Nepal
by: Gyanwali, Pradeep, et al.
Published: (2021) -
Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study.
Published: (2021) -
Responding to COVID-19: health sector preparedness, response and lessons learnt
Published: (2021) -
Covid-19: Effect of lockdown on mental and physical health.
by: Gautam, Dikshya
Published: (2020)